StockStory Touts Abercrombie & Fitch (ANF) at 7.5x Forward P/E, Passes on Caleres (CAL) and Addus HomeCare (ADUS)

On June 1, 2026, StockStory identified Abercrombie & Fitch (NYSE: ANF) as a compelling value stock, trading at a 7.5x forward price-to-earnings ratio at $77.09 per share. The research firm passed on two other apparent bargains—Caleres (NYSE: CAL) and Addus HomeCare (NASDAQ: ADUS)—warning that low multiples alone don’t guarantee safe investments. Caleres, which owns the Dr. Scholl’s brand, changed hands at $14.92, or 9.3x forward P/E. Addus HomeCare, which provides in-home personal care and hospice services for elderly and disabled clients, stood at $91.68 with a 13.3x forward multiple. StockStory did not detail specific risks in its note but stressed that value stocks often trade cheaply for fundamental reasons, requiring careful selection to avoid value traps. The commentary aligns with StockStory’s mandate to highlight durable businesses over temporary discounts. Abercrombie & Fitch’s low single-digit earnings multiple merited a “love” call, while the other two lacked sufficient support.